Jefferson University Hospitals

Alzheimer's Disease and Dementia

Related Content
alzheimersdiseaseanddementia

If you or your loved one is experiencing changes in thinking, cognition, memory, communicating or organizational tasks, you may benefit from visiting our clinic at Jefferson. Our physicians and clinicians are skilled at diagnosing and treating all types of dementia, including Alzheimer’s disease, vascular dementia, Lewy body dementia and frontotemporal dementia.

Physicians throughout the Delaware Valley and around the world refer patients with Alzheimer's disease and other neurodegenerative disorders to the Vickie and Jack Farber Institute for Neuroscience at Jefferson. Here at Jefferson, our physicians are versed in delivering state-of-the-art care for patients, while also providing resources and support for family, friends and caregivers. 

Dementia and Alzheimer’s disease affects not only the patient, but can have a great impact on family members. We make sure we dedicate time and resources to make sure your medical, psychological and social needs are met.

Clinical Trials

As an academic medical center, we offer our patients numerous opportunities to be a part of exciting clinical trials that may alter or modify the progression of dementia or Alzheimer’s disease. Some of our trials include new drug treatments, while others look for biological markers that help scientists study, and ultimately cure, dementia. Participants in research studies and clinical trials get access to new and improved treatments and are closely monitored by study staff.

Although there is no cure for Alzheimer's disease, our goal is to provide accurate diagnoses and state-of-the-art treatment. We are also involved in basic science research that is advancing fundamental knowledge of dementia-related disorders and paving the way for new methods of treatment.

At the Farber Institute for Neuroscience, patients with Alzheimer's disease can participate in clinical trials with promising investigational treatments for the disease. Most of these studies are multicenter, multiyear trials that have already met a number of rigorous standards for safety and efficacy and have shown promising early results.

For many patients and their families, participation not only offers the hope of slowing the disease but also represents a chance to share personal experience and contribute to new scientific knowledge. Patients who agree to participate must be able to consent to the study and caregivers who support that participation act as surrogate decision-makers and provide informed consent.

To learn more about clinical trials for Alzheimer's disease, please contact the Center’s coordinator, Julie, at 215-503-1275.

Leadership

Request an Appointment

To learn more about the services we offer for Alzheimer's disease and dementia, or to make an appointment, call 1-800-JEFF-NOW (1-800-533-3669).